Study of KN046 With Chemotherapy in First Line Advanced NSCLC
Clinical trial NCT04054531 · UNKNOWN
Trial details
- NCT number
- NCT04054531
- Sponsor
- Jiangsu Alphamab Biopharmaceuticals Co., Ltd
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-04
- Primary completion
- 2021-03-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.